Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Monitoring and Auditing

Posted on By

Standard Operating Procedure for Monitoring and Auditing in Clinical Research

Purpose

This SOP outlines the procedures for monitoring and auditing in clinical trials and clinical studies. The goal is to ensure study compliance with protocols, regulatory requirements, and good clinical practice (GCP) standards.

Scope

This SOP applies to all personnel involved in monitoring and auditing activities, including principal investigators, clinical research coordinators, monitors, auditors, and other study team members.

Responsibilities

  • Principal Investigator (PI): Ensures compliance with the study protocol and facilitates monitoring and auditing activities.
  • Clinical Research Coordinators: Assist in preparing for monitoring and auditing visits and implement corrective actions as needed.
  • Monitors: Review study activities and data for compliance with the protocol and regulations.
  • Auditors: Perform independent audits to assess compliance and identify areas for improvement.
See also  Clinical Studies: SOP for Participant Recruitment and Screening

Procedure

  • Monitoring:
    • Conduct routine monitoring visits to assess study compliance with the protocol, GCP, and regulatory requirements.
    • Review study documents, including case report forms (CRFs), informed consent forms (ICFs), and source documentation.
    • Observe study procedures and verify that they are being conducted as per the protocol.
    • Document monitoring findings and communicate any issues to the study team.
    • Recommend corrective actions and follow up on their implementation.
  • Auditing:
    • Plan and conduct independent audits to assess study compliance with regulatory and institutional standards.
    • Review study records, including regulatory documents, logs, and reports.
    • Assess data integrity
and quality, including data collection and management processes.
  • Identify areas of non-compliance and recommend corrective actions.
  • Document audit findings and report them to the study team and sponsor.
  • Follow-Up and Corrective Actions:
    • Work with the study team to address monitoring and audit findings.
    • Implement corrective actions to resolve identified issues.
    • Conduct follow-up visits or audits to verify that corrective actions have been implemented effectively.
  • Abbreviations Used

    • SOP: Standard Operating Procedure
    • PI: Principal Investigator
    • GCP: Good Clinical Practice
    • CRF: Case Report Form
    • ICF: Informed Consent Form

    Documents

    • Monitoring and audit plans
    • Monitoring visit reports
    • Audit reports
    • Corrective action plans

    References

    • Regulatory guidelines (e.g., FDA, EMA, ICH-GCP)
    • Institutional policies and procedures

    SOP Version

    Version: 1.0

    See also  SOP for Vendor and Third-Party Management
    Clinical Studies Tags:Adverse event reporting, Clinical data management, Clinical data validation, Clinical research compliance, Clinical research coordination, Clinical site selection, clinical studies, clinical study, Clinical study protocols, Clinical trial management, Clinical trial monitoring, Clinical trial participants, Clinical trial procedures, Clinical trial SOPs, clinical trials, Conflict of interest management, Data collection methods, Data management SOPs, eCRF validation, Electronic record-keeping guidelines, Electronic systems validation, Ethics committee reporting, Investigator training protocols, Participant data privacy, Participant recruitment strategies, Pharmacovigilance protocols, Quality assurance practices, Regulatory compliance procedures, Risk management procedures, Safety monitoring procedures, Site selection criteria, Study protocol development

    Post navigation

    Previous Post: SOP for Safety Monitoring and Reporting
    Next Post: Clinical Studies: SOP for Documentation and Record-Keeping

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version